Accéder au contenu
Merck

Efficacy of diclazuril in the prevention and cure of intestinal and hepatic coccidiosis in rabbits.

Veterinary parasitology (1989-07-15)
O Vanparijs, L Hermans, L van der Flaes, R Marsboom
RÉSUMÉ

The efficacy of diclazuril against intestinal and hepatic coccidiosis was studied in artificially infected rabbits. Prophylaxis against intestinal coccidiosis was evaluated using a mixed infection of Eimeria intestinalis, Eimeria magna and Eimeria perforans. Continuous medication in the feed at 1 p.p.m. was 100% effective in reducing oocyst output and faecal scores, and weight gain and feed efficiency were normal. Hepatic coccidiosis induced by Eimeria stiedai was prevented at 0.5 and 1 p.p.m. as shown by negative oocyst counts, normal liver weight, absence of liver lesions, and normal body-weight gain and feed efficiency. Medication at 1 p.p.m. for 7 consecutive days during the prepatent phase of hepatic coccidiosis resulted in large reductions in oocyst counts and lesion scores with a normal liver weight and growth performance. Diclazuril at 1 p.p.m. in the feed prevented both intestinal and hepatic coccidiosis in rabbits and can be advocated for safe mass medication.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Robenidine hydrochloride, VETRANAL®, analytical standard